Literature DB >> 16246311

The journey from NADPH-cytochrome P450 oxidoreductase to nitric oxide synthases.

Bettie Sue Siler Masters1.   

Abstract

This mini-review will reflect the perspective of its author on two fields of research, which have merged as the result of the insights of investigators whose work has influenced both areas immeasurably. It cannot be overlooked, however, that the research activities of many during a period of over five decades have produced the chemical and biological bases for the exciting discoveries now encompassing the cytochromes P450 and their redox partners, and the three isoforms of nitric oxide synthase as they function in their respective biological milieux. Following the remarkable discovery that, indeed, molecular oxygen can be adducted to organic molecules by enzymatic systems and that such processes require a supply of reducing equivalents, it is the purpose of this review to provide a chart, with some of its detours, of the road that followed in the pursuit of interesting biological phenomena involving these two major oxygenation systems. It is not intended to be a balanced review and apologies must be offered in advance to those whose contributions may be overlooked or simply were not directly germane to the development of the author's journey.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246311     DOI: 10.1016/j.bbrc.2005.09.165

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations.

Authors:  Ningwu Huang; Vishal Agrawal; Kathleen M Giacomini; Walter L Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-29       Impact factor: 11.205

Review 2.  Pharmacogenetics in Jewish populations.

Authors:  Yao Yang; Inga Peter; Stuart A Scott
Journal:  Drug Metabol Drug Interact       Date:  2014

3.  Identification of six novel P450 oxidoreductase missense variants in Ashkenazi and Moroccan Jewish populations.

Authors:  Mária Tomková; Christopher C Marohnic; David Gurwitz; Ondřej Seda; Bettie Sue Siler Masters; Pavel Martásek
Journal:  Pharmacogenomics       Date:  2012-04       Impact factor: 2.533

4.  A kinetic model linking protein conformational motions, interflavin electron transfer and electron flux through a dual-flavin enzyme-simulating the reductase activity of the endothelial and neuronal nitric oxide synthase flavoprotein domains.

Authors:  Mohammad M Haque; Claire Kenney; Jesús Tejero; Dennis J Stuehr
Journal:  FEBS J       Date:  2011-09-15       Impact factor: 5.542

5.  FMN binding site of yeast NADPH-cytochrome P450 reductase exposed at the surface is highly specific.

Authors:  Alexis S Ivanov; Oksana V Gnedenko; Andrey A Molnar; Alexander I Archakov; Larissa M Podust
Journal:  ACS Chem Biol       Date:  2010-08-20       Impact factor: 5.100

Review 6.  Why We Need to Take a Closer Look at Genetic Contributions to CYP3A Activity.

Authors:  Qinglian Zhai; Maaike van der Lee; Teun van Gelder; Jesse J Swen
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

Review 7.  NADPH-cytochrome P450 oxidoreductase: prototypic member of the diflavin reductase family.

Authors:  Takashi Iyanagi; Chuanwu Xia; Jung-Ja P Kim
Journal:  Arch Biochem Biophys       Date:  2012-09-11       Impact factor: 4.013

8.  The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients.

Authors:  Ingrid Lunde; Sara Bremer; Karsten Midtvedt; Beata Mohebi; Miriam Dahl; Stein Bergan; Anders Åsberg; Hege Christensen
Journal:  Eur J Clin Pharmacol       Date:  2014-06       Impact factor: 2.953

9.  Exploring the Role of CYP3A4 Mediated Drug Metabolism in the Pharmacological Modulation of Nitric Oxide Production.

Authors:  José Pérez-Del Palacio; Caridad Díaz; Noemí Vergara; Francesca Algieri; Alba Rodríguez-Nogales; Nuria de Pedro; M Elena Rodríguez-Cabezas; Olga Genilloud; Julio Gálvez; Francisca Vicente
Journal:  Front Pharmacol       Date:  2017-04-12       Impact factor: 5.810

10.  Effects of cytochrome P450 oxidoreductase genotypes on the pharmacokinetics of amlodipine in healthy Korean subjects.

Authors:  Ji Min Han; Jeong Yee; Jee Eun Chung; Kyung Eun Lee; Kyungsoo Park; Hye Sun Gwak
Journal:  Mol Genet Genomic Med       Date:  2020-03-05       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.